文献速递衰弱、肌少症与跌倒

全外显子组测序发现肌少症性肥胖相关遗传变异

Exome-Wide Sequencing Study Identified Genetic Variants Associated With Sarcopenic Obesity.
PubMed 文献 · J Gerontol A Biol Sci Med Sci · 2024-01-01

该研究在UK Biobank队列中对肌少症性肥胖(SO)开展大规模外显子组关联分析,测序样本含2 887例病例和113 284例对照,插补样本含4 003例病例和161 990例对照。单变异分析发现1q41位点(先导SNP rs1417066,LYPLAL1-AS1)与SO在全外显子组显著性水平相关;基于基因的罕见功能缺失变异负荷检验识别出PDE3B、MYOZ3、SLC15A3、RNF130、TNK2共5个基因。研究揭示了常见与罕见变异对SO易感性的遗传效应,拓展了对SO遗传结构的认识。

要点

  • 1q41位点rs1417066(LYPLAL1-AS1)与肌少症性肥胖在全外显子组水平显著相关。
  • 罕见功能缺失变异负荷检验识别PDE3B、MYOZ3、SLC15A3、RNF130、TNK2共5个基因。
  • LYPLAL1-AS1在多个肌肉骨骼相关组织中与SO共定位,提示其遗传机制。

核心结论

  • 常见变异位点1q41(rs1417066,LYPLAL1-AS1)与罕见功能缺失变异所涉5个基因均与肌少症性肥胖易感性相关。
  • 研究揭示了常见与罕见变异对SO的遗传效应,拓展了对SO遗传结构的认识。

研究设计与样本

  • 基于UK Biobank队列的外显子组关联分析,测序样本为2 887例病例和113 284例对照。
  • 插补样本为4 003例病例和161 990例对照。

主要发现

  • 单变异分析识别1q41位点先导SNP rs1417066(LYPLAL1-AS1),OR=1.15,95%CI为1.11-1.19,p=1.75×10-14。
  • 共定位分析显示LYPLAL1-AS1在多个肌肉骨骼相关组织中与SO共定位。
  • 罕见功能缺失变异负荷检验识别5个基因:PDE3B(OR=2.48,p=1.10×10-6)、MYOZ3(OR=25.49,p=1.41×10-7)、SLC15A3(OR=4.75,p=6.82×10-7)、RNF130(OR=25.83,p=4.07×10-6)、TNK2(OR=4.25,p=8.75×10-8)。

关键数值与推荐

  • 外显子组显著性水平定义为p<1×10-8。
  • 基因水平显著性水平定义为p<4.3×10-6。

临床怎么用

  • 为理解肌少症性肥胖的遗传机制提供候选位点与基因,尚不能直接用于临床基因检测或风险预测。
  • 提示LYPLAL1-AS1等位点经肌肉骨骼相关组织参与SO,可作为后续机制研究方向。

局限性

  • 研究基于UK Biobank队列,遗传关联结果的外推性需在其他人群中验证。
  • 未报告基因变异对临床干预或预后的影响。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Sarcopenic obesity (SO) is an age-related disease characterized by the coexistence of excessive adiposity and low muscle mass or function. Although obesity and sarcopenia are heritable conditions, the genetic determinants of SO have not been fully understood. We conducted a large-scale exome-wide association analysis of SO in a sequenced sample of 2 887 cases and 113 284 controls and an imputed sample of 4 003 cases and 161 990 controls in the UK Biobank cohort. Single-variant association analysis identified one locus 1q41 (lead SNP rs1417066, LYPLAL1-AS1, odds ratio [OR] = 1.15, 95% confidence interval [CI] = [1.11-1.19], p = 1.75 × 10-14) that was significantly associated with SO at the exome-wide significance level (p < 1 × 10-8). Colocalization analysis in the Genotype-Tissue Expression expression quantitative trait locus database showed that LYPLAL1-AS1 was colocalized with SO in multiple musculoskeletal-related tissues. Gene-based burden test of rare loss-of-function variants identified 5 genes at the gene-wise significance level (p < 4.3 × 10-6): PDE3B (OR = 2.48, p = 1.10 × 10-6), MYOZ3 (OR = 25.49, p = 1.41 × 10-7), SLC15A3 (OR = 4.75, p = 6.82 × 10-7), RNF130 (OR = 25.83, p = 4.07 × 10-6), and TNK2 (OR = 4.25, p = 8.75 × 10-8). Overall, our study uncovered the genetic effects of both common and rare variants on SO susceptibility, expanded existing knowledge of the genetic architecture of SO, and improved understanding of the genetic mechanisms underlying SO.

来源:J Gerontol A Biol Sci Med Sci,查看原文。版权归原作者所有。

引用

  1. Xu Q, Zhao QG, Ma XL, et al. Exome-Wide Sequencing Study Identified Genetic Variants Associated With Sarcopenic Obesity. J Gerontol A Biol Sci Med Sci. 2024. PMID: 38267387. doi:10.1093/gerona/glae025

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。